Using Recombinant Lactococci as an Approach to Dissect the Immunomodulating Capacity of Surface Piliation in Probiotic Lactobacillus rhamnosus GG

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  von Ossowski, Ingemar ^a   Pietilä, Taija E ^a   Rintahaka, Johanna ^a   Nummenmaa, Elina ^a   Mäkinen, Veli Matti ^a   Reunanen, Justus ^a   Satokari, Reetta ^a,b   de Vos, Willem M ^a,c,d   Palva, Ilkka ^a   Palva, Airi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL STRAIN; BACTERIUM PILUS; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS LACTIS; MONOCYTE; NONHUMAN; OPERON; SIGNAL TRANSDUCTION;

BACTERIAL ADHESION; CYTOKINES; DENDRITIC CELLS; DNA, RECOMBINANT; FIMBRIAE, BACTERIAL; GENETIC ENGINEERING; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS; MUCUS; PROBIOTICS; SIGNAL TRANSDUCTION; SURFACE PROPERTIES; TOLL-LIKE RECEPTOR 2;

EID: 84877764203     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064416     Document Type: Article

References (53)

1. Wall R, Fitzgerald G, Hussey S, Ryan T, Murphy B, et al. (2007) Genomic diversity of cultivable Lactobacillus populations residing in the neonatal and adult gastrointestinal tract. FEMS Microbiol Ecol 59: 127-137.
2. Dicks LM, Botes M, (2010) Probiotic lactic acid bacteria in the gastro-intestinal tract: health benefits, safety and mode of action. Benef Microbes 1: 11-29.
3. Doron S, Gorbach SL, (2006) Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 4: 261-275.
4. Tannock GW, (2004) A special fondness for lactobacilli. Appl Environ Microbiol 70: 3189-394.
5. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, et al. (1999) Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65: 351-354.
6. Bonetti A, Morelli L, Campominosi E, (2002) Assessment of the persistence in the human intestinal tract of two probiotic lactobacilli Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688. Microb Ecol Health Dis 14: 228-232.
7. de Champs C, Maroncle N, Balestrino D, Rich C, Forestier C, (2003) Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J Clin Microbiol 41: 1270-1273.
8. Salminen S, Nybom S, Meriluoto J, Collado MC, Vesterlund S, et al. (2010) Interaction of probiotics and pathogens--benefits to human health? Curr Opin Biotechnol 21: 157-167.
9. Yan F, Polk DB, (2011) Probiotics and immune health. Curr Opin Gastroenterol 27: 496-501.
10. Tsai YT, Cheng PC, Pan TM, (2012) The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96: 853-862.
11. Wells JM (2011) Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact 10: Suppl 1, S17.
12. Yebra MJ, Monedero V, Perez-Martinez G, Rodriguez-Diaz J (2012) Genetically engineered lactobacilli for technological and functional food applications. In: Valdez B, editors. Food industrial processes- methods and equipment. Rijeka, Croatia: InTech. pp. 144-168.
13. Lebeer S, Vanderleyden J, De Keersmaecker SC, (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8: 171-184.
14. Doron S, Snydman DR, Gorbach SL, (2005) Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin North Am 34: 483-498.
15. Claes IJ, Schoofs G, Regulski K, Courtin P, Chapot-Chartier MP, et al. (2012) Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG. PLoS One 7: e31588.
16. Lebeer S, Claes IJ, Balog CI, Schoofs G, Verhoeven TL, et al. (2012) The major secreted protein Msp1/p75 is O-glycosylated in Lactobacillus rhamnosus GG. Microb Cell Fact 11: 15.
17. Yan F, Polk DB, (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277: 50959-50965.
18. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, et al. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132: 562-575.
19. Seth A, Yan F, Polk DB, Rao RK, (2008) Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 294: G1060-G1069.
20. Yan F, Cao H, Cover TL, Washington MK, Shi Y, et al. (2011) Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 121: 2242-2253.
21. Lebeer S, Claes IJ, Verhoeven TL, Vanderleyden J, De Keersmaecker SC, (2011) Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol 4: 368-374.
22. Claes IJ, Segers ME, Verhoeven TL, Dusselier M, Sels BF, et al. (2012) Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb Cell Fact 11: 161.
23. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, et al. (2009) Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci USA 106: 17193-17198.
24. Danne C, Dramsi S, (2012) Pili of Gram-positive bacteria: roles in host colonization. Res Microbiol 163: 645-658.
25. Reunanen J, von Ossowski I, Hendrickx AP, Palva A, de Vos WM, (2012) Characterization of the SpaCBA pilus fibers in the probiotic Lactobacillus rhamnosus GG. Appl Environ Microbiol 78: 2337-2344.
26. von Ossowski I, Reunanen J, Satokari R, Vesterlund S, Kankainen M, et al. (2010) Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol 76: 2049-2057.
27. Lebeer S, Claes I, Tytgat HL, Verhoeven TL, Marien E, et al. (2012) Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78: 185-193.
28. Douillard FP, Ribbera A, Järvinen HM, Kant R, Pietilä TE, et al. (2013) Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics. Appl Environ Microbiol 79: 1923-1933.
29. Bahey-El-Din M, Gahan CG, Griffin BT, (2010) Lactococcus lactis as a cell factory for delivery of therapeutic proteins. Curr Gene Ther 10: 34-45.
30. García-Fruitós E, (2012) Lactic acid bacteria: a promising alternative for recombinant protein production. Microb Cell Fact 11: 157.
31. Morello E, Bermúdez-Humarán LG, Llull D, Solé V, Miraglio N, et al. (2008) Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 14: 48-58.
32. Buccato S, Maione D, Rinaudo CD, Volpini G, Taddei AR, et al. (2006) Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease. J Infect Dis 194: 331-340.
33. Maisey HC, Quach D, Hensler ME, Liu GY, Gallo RL, et al. (2008) A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J 22: 1715-1724.
34. Quigley BR, Hatkoff M, Thanassi DG, Ouattara M, Eichenbaum Z, et al. (2010) A foreign protein incorporated on the Tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity. Infect Immun 78: 1294-1303.
35. Vélez MP, Petrova MI, Lebeer S, Verhoeven TL, Claes I, et al. (2010) Characterization of MabA, a modulator of Lactobacillus rhamnosus GG adhesion and biofilm formation. FEMS Immunol Med Microbiol 59: 386-398.
36. von Ossowski I, Satokari R, Reunanen J, Lebeer S, De Keersmaecker SC, et al. (2011) Functional characterization of a mucus-specific LPXTG surface adhesin from probiotic Lactobacillus rhamnosus GG. Appl Environ Microbiol 77: 4465-4472.
37. Kelly D Mulder IE (2012) Microbiome and immunological interactions. Nutr Rev 70Suppl 1, 18-30.
38. Lavelle EC, Murphy C, O'Neill LA, Creagh EM, (2010) The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 3: 17-28.
39. Basset A, Zhang F, Benes C, Sayeed S, Herd M, et al. (2013) Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein. J Biol Chem 288: 2665-2675.
40. Schmidt SV, Nino-Castro AC, Schultze JL, (2012) Regulatory dendritic cells: there is more than just immune activation. Front Immunol 3: 274.
41. Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, et al. (2007) A key role of dendritic cells in probiotic functionality. PLoS One 2: e313.
42. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A, (2012) Probiotic mechanisms of action. Ann Nutr Metab 61: 160-174.
43. Rajput IR, Li WF, (2012) Potential role of probiotics in mechanism of intestinal immunity. Pak Vet J 32: 303-308.
44. Latvala S, Pietila TE, Veckman V, Kekkonen RA, Tynkkynen S, et al. (2008) Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J Gastroenterol 14: 5570-5583.
45. Kosaka A, Yan H, Ohashi S, Gotoh Y, Sato A, et al. (2012) Lactococcus lactis subsp. cremoris FC triggers IFN-γ production from NK and T cells via IL-12 and IL-18. Int Immunopharmacol 14: 729-733.
46. de Ruyter PG, Kuipers OP, Beerthuyzen MM, van Alen-Boerrigter I, de Vos WM, (1996) Functional analysis of promoters in the nisin gene cluster of Lactococcus lactis. J Bacteriol 178: 3434-3439.
47. de Ruyter PG, Kuipers OP, de Vos WM, (1996) Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol 62: 3662-3667.
48. Higuchi R, Krummel B, Saiki RK, (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16: 7351-7367.
49. Holo H, Nes IF, (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osomotically stabilized media. Appl Environ Microbiol 55: 3119-3123.
50. Ouwehand AC, Salminen S, Tölkkö S, Roberts P, Ovaska J, et al. (2002) Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin Diagn Lab Immunol 9: 184-186.
51. Vesterlund S, Paltta J, Karp M, Ouwehand AC, (2005) Measurement of bacterial adhesion-in vitro evaluation of different methods. J Microbiol Methods 60: 225-233.
52. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S, (1999) Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 162: 7322-7329.
53. Veckman V, Miettinen M, Pirhonen J, Sirén J, Matikainen S, et al. (2004) Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol 75: 764-771.